Sunshine Biopharma, Inc. (SBFM) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Sunshine Biopharma, Inc. (SBFM) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $2.1M, listed on NASDAQ, employing roughly 52 people, carrying a beta of 1.49 to the broader market. Sunshine Biopharma, Inc. Led by Steve N. Slilaty, public since 2022-02-15.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for SBFM as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →